Tag: fixed-dose combination
Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products like fixed-dose pills, topical creams, and inhalers is far more complex than for single-drug generics. Regulatory hurdles, high costs, and inconsistent methods delay affordable access to these essential medicines.